Veli Yazısız, et al. “The Use of Anti-Interleukin-1 Agents and Tumor Necrosis factor‐alpha Inhibitors in Renal Transplant Recipients”. Archives of Rheumatology, vol. 36, no. 3, Sept. 2021, pp. 366-74, doi:10.46497/ArchRheumatol.2021.8500.